SKU Code: AERAS3100
Aerogen Solo Nebuliser
Sold as Each
The Aerogen Solo is uniquely designed remaining in place during ventilation. This closed system delivers more inhaled medication to the lungs, in less time, with less residual volume, compared to jet nebulizers, giving confidence in a more effective and controlled treatment.
The medication reservoir is isolated from the breathing circuit which minimizes nebulization of contaminated fluids. The risk of exposure to bioaerosols is reduced because the need to open the circuit is eliminated.
It delivers more effective medication throughout the hospital through mechanical ventilation and non-invasive support such as non-invasive ventilation (NIV), high flow therapies (HFNC) and spontaneously breathing patients. This only requires minimal management and can be left inline reducing staff handling and workload.
1. Dunne RB, Shortt S. Comparison of bronchodilator administration with vibrating mesh nebulizer and standard jet nebulizer in the emergency department. Am J Emerg Med 2018; 4: 641–646.
2. Moody GB, Luckett PM, Shockley CM, Huang R, Ari A. Clinical Efficacy of Vibrating Mesh and Jet Nebulizers With Different Interfaces in Pediatric Subjects With Asthma. Respir Care 2020; : respcare.07538.
3 .Cantu T, et al. Quality Improvement Project to Compare Vibrating Mesh Nebulizer Therapy With Hour Long Jet Nebulizer Therapy for Albuterol Delivery in Asthma and Reactive Airway Disorder Patients in a Pediatric Emergency Department. Respiratory Care October 2019, 64 (Suppl 10) 3238888.
4. Dugernier J, Hesse M, Vanbever R, Depoortere V, Roeseler J, Michotte JB et al. SPECT-CT Comparison of Lung Deposition using a System combining a Vibrating-mesh Nebulizer with a Valved Holding Chamber and a Conventional Jet Nebulizer: a Randomized Cross-over Study. Pharm Res 2017; 34: 290–300
5. Hickin S, Mac Loughlin R, Sweeney L, Tatham A, Gidwani S. Comparison of mesh nebulizer versus jet nebulizer in simulated adults with chronic obstructive pulmonary disease. Poster Coll Emerg Med Clin Excell Conf 2014.
6. Abdelrahim ME, Plant P, Chrystyn H. In-vitro characterisation of the nebulised dose during non-invasive ventilation. J Pharm Pharmacol 2010;62(8):966–972
7.Aerogen Instruction Manual
8. Ari A. Practical strategies for a safe and effective delivery of aerosolized medications to patients with COVID-19. Respir. Med. 2020; 167. doi:10.1016/j.rmed.2020.105987.
9. Dugernier J, Reychler G, Wittebole X, et al. Aerosol delivery with two ventilation modes during mechanical ventilation: a randomized study. Ann Intensive Care 2016;6(1):73
10. Miller A, Epstein D. Safe bronchodilator treatment in mechanically ventilated COVID-19 patients: A single center experience. J. Crit. Care. 2020; 58: 56–57.
|Unit Of Measure||ea|
Fisher & Paykel